GP sees patient with vCJD improve
Dr Mark McClean has reported cautious signs of improvement in one of his patients with variant Creutzfeldt-Jakob disease (vCJD) who is being treated with a revolutionary new drug.
Dr McClean, a GP in Belfast, said his patient, 18-year-old Jonathan Simms, was 'bound to die' a year ago but since starting treatment with the experimental drug Pentosan in January, the deterioration has stopped.
Jonathan had to fight a High Court battle to have the treatment as the drug at that stage had only been tested on dogs and mice.
Dr McClean said: 'He has demonstrated greater response to auditory, visual and tactile stimuli.'